MenQuadfi

Ülke: Avrupa Birliği

Dil: Fince

Kaynak: EMA (European Medicines Agency)

Aktif bileşen:

Neisseria meningitidis group C polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis group A polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis group Y polysaccharide conjugated to tetanus toxoid, Neisseria meningitidis group W-135 polysaccharide conjugated to tetanus toxoid

Mevcut itibaren:

Sanofi Pasteur

ATC kodu:

J07AH08

INN (International Adı):

meningococcal group A, C, W-135 and Y conjugate vaccine

Terapötik grubu:

rokotteet

Terapötik alanı:

Meningiitti, meningokokki

Terapötik endikasyonlar:

MenQuadfi is indicated for active immunisation of individuals from the age of 12 months and older against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W, and Y. The use of this vaccine should be in accordance with available official recommendations.

Ürün özeti:

Revision: 8

Yetkilendirme durumu:

valtuutettu

Yetkilendirme tarihi:

2020-11-18

Bilgilendirme broşürü

504 GATEWAY TIME-OUT

Ürün özellikleri

504 GATEWAY TIME-OUT